by Peggy Darius, Leipzig University Graphical abstract. Credit: Cancer Research (2022). DOI: 10.1158/0008-5472.can-21-1908 Although there has been significant progress in the treatment of rare forms of blood cancer in recent years and new drugs have been approved in Germany, the prognosis for many affected individuals remains unfavorable. Research teams at Leipzig University’s Faculty of Medicine are working...
